Anixa Biosciences Initiates Treatment for Second Group in Phase 1 Clinical Trial for Revolutionary CART Therapy Targeting Ovarian Cancer
On February 12, 2024, Anixa Biosciences, a pioneering biotechnology company, commenced treatment for the fourth participant in their groundbreaking Phase ...
